LEMAITRE VASCULAR, INC. (LMAT) Capital expenditures 2016–2025
LEMAITRE VASCULAR, INC. (LMAT) annual capital expenditure history — cash spent on property, plant and equipment, per SEC filings.
$6.8MFY2025 · since FY2016: $2.8M → $6.8M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $6.8M | -2.6% |
| FY2024 | $7.0M | -4.2% |
| FY2023 | $7.3M | +125.0% |
| FY2022 | $3.2M | -33.9% |
| FY2021 | $4.9M | +63.7% |
| FY2020 | $3.0M | -20.7% |
| FY2019 | $3.8M | +23.1% |
| FY2018 | $3.1M | -52.4% |
| FY2017 | $6.4M | +125.9% |
| FY2016 | $2.8M | — |
Capital expenditures are shown as the positive cash amount spent, as reported on the cash-flow statement.
Source: SEC XBRL filings · For reference only · Not investment advice